The shortest measure of inflation expectations, the 2-year break-even, has fallen from nearly 3% at the start of the year to 2.50% today. The market doesn’t seem overly concerned with tariffs ...

Summit Therapeutics is aggressively pursuing U.S. approval for ivonescimab in NSCLC, despite lacking statistically ...

Enpatoran, a first-in-class oral small molecule toll-like receptor 7/8 inhibitor, is superior to placebo in improving mucocutaneous symptoms of cutaneous and systemic lupus, according to data ...

Home values rose for the first time in seven months in September, according to the Zillow Home Value Index. Read more here.

AUSTRALIA – Market research analysis and reporting platform Displayr has launched an AI assistant to automate data cleaning ...

Discover how the nominal effective exchange rate (NEER) measures currency competitiveness globally, and learn how the NEER impacts forex markets and trade policy analysis.

On track for its biggest yearly rise since 1979, gold's 54% rise year to date has seen it break through key psychological ...

Silver is once again deeply undervalued, sitting at the edge of a major revaluation. Consider gaining exposure through silver ...

The whole process begins with capturing of data at the real time when transactions are taking place, and goes through to ...

After 5 years, Kisqali® plus endocrine therapy consistently shows significant and clinically meaningful benefit in invasive disease-free survival1 Kisqali remains the only CDK4/6 inhibitor ...

Data published in the American Journal of Gastroenterology showed rapid and sustained relief of nighttime gastroesophageal reflux disease (GERD) symptoms in patients treated with VOQUEZNA, including c ...